Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations | American Journal of Respiratory and Critical Care Medicine | 2016 | 1.5K |
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report | American Journal of Respiratory and Critical Care Medicine | 2016 | 653 |
The impact of PM2.5 on the human respiratory system | Journal of Thoracic Disease | 2016 | 489 |
Treatable traits: toward precision medicine of chronic airway diseases | European Respiratory Journal | 2016 | 487 |
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management | European Respiratory Journal | 2016 | 396 |
Long-Term Ozone Exposure and Mortality in a Large Prospective Study | American Journal of Respiratory and Critical Care Medicine | 2016 | 366 |
Obstructive sleep disordered breathing in 2- to 18-year-old children: diagnosis and management | European Respiratory Journal | 2016 | 349 |
Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial | American Journal of Respiratory and Critical Care Medicine | 2016 | 293 |
Risk factors for lung cancer worldwide | European Respiratory Journal | 2016 | 280 |
Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study | European Respiratory Journal | 2016 | 275 |
Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study | American Journal of Respiratory and Critical Care Medicine | 2016 | 260 |
Diagnostic Yield and Complications of Bronchoscopy for Peripheral Lung Lesions. Results of the AQuIRE Registry | American Journal of Respiratory and Critical Care Medicine | 2016 | 250 |
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD | Thorax | 2016 | 246 |
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials | Respiratory Medicine | 2016 | 245 |
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials | European Respiratory Journal | 2016 | 244 |
Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection | American Journal of Respiratory and Critical Care Medicine | 2016 | 236 |
In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011 | American Journal of Respiratory and Critical Care Medicine | 2016 | 231 |
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis | Thorax | 2016 | 230 |
What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion | European Respiratory Journal | 2016 | 229 |
Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement | European Respiratory Journal | 2016 | 229 |
Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis | American Journal of Respiratory and Critical Care Medicine | 2016 | 217 |
Air particulate matter and cardiovascular disease: the epidemiological, biomedical and clinical evidence | Journal of Thoracic Disease | 2016 | 209 |
International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety | Thorax | 2016 | 207 |
Lung microbiome dynamics in COPD exacerbations | European Respiratory Journal | 2016 | 206 |
Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease | American Journal of Respiratory and Critical Care Medicine | 2016 | 194 |